FRBRX
Price
$212.75
Change
-$0.45 (-0.21%)
Updated
Sep 11 closing price
Net Assets
1.2B
JNGLX
Price
$88.13
Change
-$0.69 (-0.78%)
Updated
Sep 10 closing price
Net Assets
6.03B
Interact to see
Advertisement

FRBRX vs JNGLX

FRBRX vs JNGLX Comparison Chart in %
View a ticker or compare two or three
VS
FRBRX vs. JNGLX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRBRX is a Hold and JNGLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 6.03B vs. FRBRX (1.2B). FRBRX pays higher dividends than JNGLX: FRBRX (1.70) vs JNGLX (0.39). FRBRX was incepted earlier than JNGLX: FRBRX (13 years) vs JNGLX (28 years). JNGLX (0.81) and FRBRX (0.78) have similar cost to investors . FRBRX is a more actively managed with annual turnover of: 37.62 vs. JNGLX (30.00). JNGLX has a lower initial minimum investment than FRBRX: JNGLX (2500) vs FRBRX (1000000). FRBRX annual gain was more profitable for investors over the last year : 43.04 vs. JNGLX (25.31). FRBRX return over 5 years is better than : 30.23 vs. JNGLX (18.64).
FRBRXJNGLXFRBRX / JNGLX
Total Expense Ratio0.670.8183%
Annual Report Gross Expense Ratio0.780.8196%
Fund Existence13 years28 years-
Gain YTD18.8018.816213%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.2B6.03B20%
Annual Yield % from dividends1.700.39439%
Returns for 1 year43.0425.31170%
Returns for 3 years81.3528.49286%
Returns for 5 years30.2318.64162%
Returns for 10 years55.2685.9764%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGGAX83.17N/A
N/A
DWS Large Cap Focus Growth A
GSMSX37.51N/A
N/A
Goldman Sachs Mid Cap Value Svc
VNIAX9.56N/A
N/A
Vontobel International Equity A
MINJX49.27N/A
N/A
MFS International Intrinsic Equity R6
FIKCX74.56N/A
N/A
Fidelity Advisor Health Care Z